Errata Corrige, Thalassemia Reports 2017; 7:6392

Referring to the article: Baiamonte E, Barone R, Contino F, et al. Granulocytecolony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile, published on Thalassemia Reports 2017; vo...

Full description

Bibliographic Details
Main Author: Editorial Office
Format: Article
Language:English
Published: MDPI AG 2017-08-01
Series:Thalassemia Reports
Online Access:http://www.pagepressjournals.org/index.php/thal/article/view/7024
_version_ 1797966817715552256
author Editorial Office
author_facet Editorial Office
author_sort Editorial Office
collection DOAJ
description Referring to the article: Baiamonte E, Barone R, Contino F, et al. Granulocytecolony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile, published on Thalassemia Reports 2017; volume 7:6392, the following sentence in the Materials and Mehods section is not correct: (Filgrastim, Amgen, Thousand Oaks, CA, USA). Corrected sentence must be intended as follows: [Myelostim 34 F 33,6 33,6 MUI (263 mcg) (Lenograstim), Italfarmaco S.P.A.]
first_indexed 2024-04-11T02:21:20Z
format Article
id doaj.art-3a166adc2584464bbcd1bb42918a4128
institution Directory Open Access Journal
issn 2039-4357
2039-4365
language English
last_indexed 2024-04-11T02:21:20Z
publishDate 2017-08-01
publisher MDPI AG
record_format Article
series Thalassemia Reports
spelling doaj.art-3a166adc2584464bbcd1bb42918a41282023-01-02T23:41:01ZengMDPI AGThalassemia Reports2039-43572039-43652017-08-017110.4081/thal.2017.70245375Errata Corrige, Thalassemia Reports 2017; 7:6392Editorial Office0Thalassemia Reports, PAGEPressReferring to the article: Baiamonte E, Barone R, Contino F, et al. Granulocytecolony stimulating factor plus plerixafor in patients with β-thalassemia major results in the effective mobilization of primitive CD34+ cells with specific gene expression profile, published on Thalassemia Reports 2017; volume 7:6392, the following sentence in the Materials and Mehods section is not correct: (Filgrastim, Amgen, Thousand Oaks, CA, USA). Corrected sentence must be intended as follows: [Myelostim 34 F 33,6 33,6 MUI (263 mcg) (Lenograstim), Italfarmaco S.P.A.]http://www.pagepressjournals.org/index.php/thal/article/view/7024
spellingShingle Editorial Office
Errata Corrige, Thalassemia Reports 2017; 7:6392
Thalassemia Reports
title Errata Corrige, Thalassemia Reports 2017; 7:6392
title_full Errata Corrige, Thalassemia Reports 2017; 7:6392
title_fullStr Errata Corrige, Thalassemia Reports 2017; 7:6392
title_full_unstemmed Errata Corrige, Thalassemia Reports 2017; 7:6392
title_short Errata Corrige, Thalassemia Reports 2017; 7:6392
title_sort errata corrige thalassemia reports 2017 7 6392
url http://www.pagepressjournals.org/index.php/thal/article/view/7024
work_keys_str_mv AT editorialoffice erratacorrigethalassemiareports201776392